AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2020
Apr 4, 2020
33899_dirs_2020-04-03_4518921c-3156-4e6d-aaf7-43baade7f9f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2020-04-01
Reporting Person: KELLEMAN JOSEPH P ((Interim) CFO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2740 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $66.68 | 2028-02-07 | Common Stock (1250) | Direct | |
| Stock Options | $44.73 | 2027-02-16 | Common Stock (1250) | Direct |
Footnotes
F1: Includes 237 shares of common stock underlying a restricted stock award which was granted on February 22, 2019 and will vest in equal installments on February 22, 2021 and 2022 and 449 shares of common stock underlying a restricted stock award granted on February 21, 2020 which will vest in equal installments on the first, second and third anniversary of the date of grant.
F2: Includes 417 non-qualified stock options which were granted on February 7, 2018 and will vest on February 7, 2021.
More from MEDIFAST INC
Board/Management Information
2026
Jun 1
Board/Management Information
2026
May 26
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Board/Management Information
2026
Mar 20